Clinical and molecular characteristics of ARIEL3 patients who derived exceptional benefit from rucaparib maintenance treatment for high-grade ovarian cancer (HGOC) Meeting Abstract
| Authors: | Kwan, T.; Oza, A. M.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Dean, A. P.; Colombo, N.; Weberpals, J. I.; Clamp, A. R.; Scambia, G.; Leary, A.; Holloway, R. W.; Amenedo, M.; Fong, P. C. C.; Goh, J. C.; O'Malley, D. M.; Maloney, L.; Goble, S.; Ledermann, J. A.; Coleman, R. L. |
| Abstract Title: | Clinical and molecular characteristics of ARIEL3 patients who derived exceptional benefit from rucaparib maintenance treatment for high-grade ovarian cancer (HGOC) |
| Meeting Title: | ESTRO 2021 |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120603140 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.5537 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 5537 -- Source: Wos |
